TAIM
REGN icon

Te Ahumairangi Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Te Ahumairangi Investment Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.34M Sell
4,329
-220
-5% -$168K 0.56% 65
2025
Q4 		$3.51M Sell
4,549
-1,711
-27% -$1.16M 0.63% 59
2025
Q3 		$3.52M Buy
6,260
+570
+10% +$322K 0.6% 61
2025
Q2 		$2.99M Buy
5,690
+4,278
+303% +$2.39M 0.53% 65
2025
Q1 		$896K Buy
+1,412
New +$971K 0.19% 78

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Te Ahumairangi Investment Management's REGN Position: Q1 2026 in Review

Te Ahumairangi Investment Management reduced its Regeneron Pharmaceuticals (REGN) stake by 4.8% in Q1 2026, selling an estimated $168K and leaving 4,329 shares worth $3.34M. The position accounts for 0.56% of the portfolio, ranked #65.

Te Ahumairangi Investment Management first reported a position in REGN in Q1 2025 and has held it in 5 quarters since. The position peaked at $3.52M in Q3 2025. 1,396 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Te Ahumairangi Investment Management held 4,329 shares of Regeneron Pharmaceuticals worth $3.34M as of Q1 2026.
  • Te Ahumairangi Investment Management sold 220 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $168K.
  • Regeneron Pharmaceuticals made up 0.56% of Te Ahumairangi Investment Management's portfolio in Q1 2026, its #65 holding.
  • Te Ahumairangi Investment Management first reported a position in Regeneron Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • Te Ahumairangi Investment Management's Regeneron Pharmaceuticals position peaked at $3.52M in Q3 2025.
  • 1,396 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Te Ahumairangi Investment Management's 13F filing for Q1 2026, filed 15 May 2026.